Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

INHIBITEX, INC. (INHX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-11Jun-30-11Mar-31-11Dec-31-10Sep-30-10Jun-30-10Mar-31-10Dec-31-09
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Revenue:          
License fees and milestones  1.10.1  0.10.1  
Collaborative research and development.  0.50.5  0.50.5  
    Total revenue  1.60.60.60.60.64.27.611.1
            Total revenue growth  169.6%-86.4%-92.5%-94.8%-94.8%-60.2%-16.0%23.8%
Operating expense:          
Research and development  10.39.3  9.64.9  
General and administrative  1.91.8  1.81.8  
    Total operating expense  12.111.1  11.56.7  
    Loss from operations.  -10.6-10.6  -10.9-10.1  
            Operating margin  -682.5%-1837.8%  -1891.8%-238.0%  
Other income (loss), net  0.00.0  0.00.0  
Interest income, net  0.10.0  0.00.0  
    Net loss  -10.5-10.5  -10.8-10.0  
   
Basic and diluted net loss per share  ($0.14)($0.15)  ($0.17)($0.19)  
   
Weighted average shares used to compute basic and diluted net loss per share  38.334.3  31.026.3  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy